Common Variable Immunodeficiency: Symptoms, Diagnosis, Treatment and Life Expectancy
Common variable immunodeficiency, usually shortened to CVID, is a disorder in which the immune system does not produce enough effective antibodies. These antibodies, also called immunoglobulins, normally help the body recognise and fight bacteria, viruses and other infectious organisms.
For some people, the first clue is a string of sinus infections that never seems to end. Others experience repeated chest infections, pneumonia, persistent diarrhoea or unexplained fatigue. A smaller but important group first comes to medical attention because of an autoimmune blood disorder, enlarged lymph nodes, inflammation in the lungs or another complication that does not initially look like an immune deficiency.
This wide variation is the reason for the word “variable” in the name. CVID is not one identical disease affecting everyone in the same way. It is an umbrella diagnosis covering a range of immune defects that produce a similar pattern of low immunoglobulins and poor antibody function. One person may mainly experience infections, while another develops autoimmune or inflammatory disease despite having relatively few obvious infections.
CVID is among the more frequently diagnosed symptomatic primary immunodeficiencies in adults, although it is still uncommon in the general population. Recent UK research has cited an estimated prevalence of approximately one in 25,000 to one in 50,000 people.
CVID at a glance
Common variable immunodeficiency:
Causes low levels or poor function of infection-fighting antibodies
Commonly leads to repeated sinus, ear and chest infections
Can appear during childhood or adulthood
May cause autoimmune, digestive, lung, liver or blood complications
Is diagnosed using symptoms, immunoglobulin measurements and immune-function tests
Must be distinguished from medicines and illnesses that cause secondary immunodeficiency
Is usually treated with regular immunoglobulin replacement
Is generally a lifelong condition
Varies considerably in severity and long-term outlook
CVID should not be diagnosed simply because someone catches several colds each year. The pattern, severity, duration and type of infections matter, as do laboratory findings and the exclusion of other explanations.
What does common variable immunodeficiency mean?
The name can be broken into three parts.
Common means that it is one of the more commonly recognised symptomatic primary antibody deficiencies. It does not mean that CVID is common among the general population.
Variable describes the fact that symptoms, laboratory findings, complications and severity differ greatly between affected people.
Immunodeficiency means that part of the immune system is unable to work as effectively as it should.
You may also see the term common variable immune deficiency disorders. Some specialists prefer the plural because CVID probably includes a number of biologically different disorders that have been grouped together under one clinical diagnosis.
What are immunoglobulins?
Immunoglobulins are proteins made by specialised immune cells. They recognise infectious organisms and help the immune system remove them.
The three main immunoglobulins discussed in CVID are:
Immunoglobulin G
Immunoglobulin G, or IgG, is the most abundant antibody in the bloodstream and tissues. It plays an important part in protection against many bacterial and viral infections.
A substantially reduced IgG level is central to the diagnosis of CVID.
Immunoglobulin A
Immunoglobulin A, or IgA, helps defend the moist surfaces lining the respiratory and digestive systems. It is found in blood and secretions such as saliva and tears.
IgA is often low in people with CVID.
Immunoglobulin M
Immunoglobulin M, or IgM, is produced early during an immune response. Some people with CVID have low IgM, while others retain a level within the normal range.
People with CVID generally have a low IgG level alongside reduced IgA, IgM or both. The antibodies they do produce may also work poorly. This means that the number shown on a blood test is only one part of the assessment. Doctors may also need to determine whether the immune system can produce a useful response to vaccination.
What causes CVID?
There is no single cause that explains every case.
CVID usually involves a failure of B lymphocytes to mature into plasma cells that produce effective antibodies. Other parts of the immune system, including T cells and immune-regulating pathways, may also be abnormal in some patients.
A specific genetic explanation can now be identified in a proportion of people, particularly those who develop symptoms early, have affected family members or have unusual autoimmune, inflammatory or developmental features. However, most patients do not have one clearly identifiable disease-causing genetic change.
This is why CVID remains a clinical umbrella diagnosis rather than the name of one gene disorder. Modern genetic testing is gradually reclassifying some people previously labelled as having CVID into more specific inborn errors of immunity.
Is CVID hereditary?
CVID is not inherited in a simple, predictable way in most families.
The majority of people diagnosed with CVID do not have a parent with the same diagnosis. In some families, however, more than one relative may have CVID, selective IgA deficiency, low immunoglobulins or another immune disorder.
Where a specific genetic cause is found, the inheritance pattern depends on the gene involved. It may be autosomal dominant, autosomal recessive or, less commonly, follow another pattern.
Genetic counselling may be offered when:
Symptoms began unusually early
Several relatives have immune or autoimmune disorders
The patient has severe immune dysregulation
There are developmental or neurological features
There is unexplained lymphoproliferation
The specialist suspects a defined monogenic condition
A negative genetic test does not rule out CVID. It may simply mean that current testing has not identified the underlying cause.
At what age does CVID begin?
CVID can become apparent at almost any age after early childhood.
Many diagnoses are made during the second, third or fourth decades of life. Some people remember repeated infections from childhood, while others were previously healthy and did not develop a recognisable pattern until adulthood.
The fact that someone reached adulthood without serious infections does not rule out CVID. Antibody production can deteriorate over time, and some immune complications may appear before recurrent infections become obvious. Most diagnoses are nevertheless made in adults, commonly during the third or fourth decade.
Doctors are normally cautious about making a firm CVID diagnosis in very young children because immunoglobulin levels and immune responses continue to develop during early life. Other childhood conditions, including transient hypogammaglobulinaemia of infancy, must also be considered.
What are the early symptoms of CVID?
There is no single first symptom. The earliest pattern is often repeated, unusually severe or slow-to-resolve infections.
Recurrent sinus infections
Repeated sinusitis is one of the most common presentations.
A person may experience facial pressure, nasal blockage, thick discharge, headaches or reduced smell several times a year. Symptoms may return soon after antibiotics are stopped, or the infection may never seem to clear fully.
Not every person with sinusitis has an immunodeficiency. Allergies, nasal polyps, anatomical obstruction and other common problems are much more frequent explanations. Concern increases when infections are severe, persistent, accompanied by pneumonia or associated with other unusual health problems.
Frequent ear infections
Repeated middle-ear infections are especially noticeable in adults, in whom they are less common than in children.
Children with CVID may experience recurrent ear infections, hearing difficulties or repeated courses of antibiotics.
Repeated bronchitis or pneumonia
Chest infections are among the most important warning signs.
Symptoms may include:
A cough that repeatedly returns
Green or yellow sputum
Breathlessness
Chest pain
Fever
Wheezing
Repeated diagnoses of bronchitis
More than one episode of pneumonia
Respiratory infections are particularly important because repeated inflammation can permanently damage the airways. Severe and recurrent infections can eventually contribute to bronchiectasis.
Infections that take a long time to clear
People with CVID may need longer courses of antibiotics than expected. An infection may improve but quickly return, or the same organism may repeatedly be identified.
The issue is not simply “getting ill often”. The severity, persistence, recurrence and complications of the infections create the concerning pattern.
Persistent diarrhoea or abdominal problems
CVID can affect the digestive system.
Possible symptoms include:
Persistent or recurring diarrhoea
Abdominal pain
Bloating
Nausea
Poor appetite
Unintentional weight loss
Difficulty absorbing nutrients
Digestive symptoms can arise from infections, inflammatory bowel disease-like enteropathy, reduced nutrient absorption or other CVID-associated problems. Significant gastrointestinal disease has been reported in a substantial minority of affected people.
Unexplained tiredness
Fatigue is common in CVID, although it is not specific to the condition.
Repeated infections, disturbed sleep, chronic inflammation, anaemia, lung disease, medication effects and the burden of regular treatment may all contribute. Someone with unexplained fatigue but no other suggestive findings is far more likely to have a more common cause than CVID.
Enlarged lymph nodes or spleen
Some people develop persistently enlarged lymph nodes or an enlarged spleen.
These findings can result from chronic immune stimulation and do not automatically indicate cancer. However, new, growing, firm or persistent lymph nodes require medical assessment. In some situations, imaging or biopsy is necessary because CVID is associated with both benign lymphoid enlargement and an increased risk of lymphoma.
Autoimmune symptoms
CVID can paradoxically cause both a weak response to infection and excessive immune activity against the body’s own tissues.
Autoimmune disease may occasionally be the first recognised manifestation. A person may have unexplained bruising, bleeding, anaemia or low blood-cell counts before recurrent infections lead clinicians to test immunoglobulins.
What infections occur in CVID?
The infections most strongly associated with CVID involve the respiratory tract.
These commonly include:
Sinusitis
Otitis media
Tonsillitis
Bronchitis
Pneumonia
Pleurisy
Bacterial infections are particularly common, but viral, parasitic and fungal infections can also occur. The ears, sinuses, lungs and bowel are vulnerable because they are regularly exposed to organisms from the environment.
Some patients experience gastrointestinal infections, including persistent infections that cause diarrhoea and weight loss. Others may develop unusual or severe viral infections.
The exact infection pattern differs according to the person’s remaining immune function, treatment, exposure and any existing organ damage.
When do frequent infections suggest an immune deficiency?
Having several coughs, colds or minor viral illnesses does not necessarily indicate CVID, particularly in young children, healthcare workers or people regularly exposed to large groups.
Features more likely to justify an immune assessment include:
Repeated bacterial sinus or chest infections
More than one pneumonia
Infections that are unusually severe
Repeated hospital admissions for infection
Persistent infection despite appropriate treatment
A need for prolonged or intravenous antibiotics
Poor growth or unexplained weight loss
Chronic diarrhoea
Bronchiectasis without a clear cause
Unusual organisms
A combination of infections and autoimmunity
A family history of immunodeficiency
These signs do not prove that a person has CVID. They indicate that further investigation may be reasonable.
Can CVID cause autoimmune disease?
Yes. Autoimmunity is one of the most important non-infectious features of CVID.
The immune system is not simply “weak”. It is dysregulated. The same person can have difficulty producing protective antibodies while also developing immune attacks against their own blood cells or tissues.
Autoimmune blood disorders are particularly recognised, including:
Immune thrombocytopenia
Immune thrombocytopenia, or ITP, occurs when the immune system destroys platelets. Symptoms may include easy bruising, nosebleeds, bleeding gums, heavy menstrual bleeding or small red-purple skin spots called petechiae.
Autoimmune haemolytic anaemia
In autoimmune haemolytic anaemia, red blood cells are destroyed prematurely. Possible symptoms include tiredness, breathlessness, paleness, jaundice and dark urine.
Autoimmune neutropenia
Neutrophils are white blood cells that help defend against infection. Autoimmune destruction can lead to a low neutrophil count and additional infection risk.
These autoimmune cytopenias can appear before CVID has been diagnosed and may recur over time.
Other autoimmune or inflammatory conditions may affect the joints, thyroid, skin, digestive tract or other organs.
How does CVID affect the lungs?
Lung health is a major part of long-term CVID care.
Bronchiectasis
Bronchiectasis is permanent widening and damage of the airways. It can develop after repeated or severe respiratory infections.
Symptoms can include:
A long-standing productive cough
Repeated chest infections
Breathlessness
Wheezing
Coughing up blood
Reduced exercise tolerance
Once bronchiectasis is established, mucus can collect in the widened airways, making further infection more likely. This creates a cycle of infection, inflammation and additional airway damage.
Immunoglobulin replacement aims not only to reduce immediate illness but also to prevent this type of permanent lung injury.
Granulomatous-lymphocytic interstitial lung disease
Some people with CVID develop inflammatory lung disease rather than, or in addition to, infection-related airway damage.
The best-known form is granulomatous-lymphocytic interstitial lung disease, usually shortened to GLILD. This involves abnormal collections of immune cells and inflammation within the lungs.
Possible symptoms include:
Persistent dry cough
Increasing breathlessness
Reduced exercise capacity
Fatigue
Abnormal lung-function results
Changes seen on a chest CT scan
GLILD is not an infection, although infection must be excluded before immunosuppressive treatment is considered. It is an important contributor to illness and poorer outcomes in complicated CVID. Diagnosis and treatment often require joint assessment by immunology, respiratory medicine, radiology and pathology specialists.
How can CVID affect the digestive system?
Digestive disease in CVID can arise from several different mechanisms.
A person may have:
Persistent gastrointestinal infection
Malabsorption
Inflammatory enteropathy
Inflammatory bowel disease-like illness
Reduced levels of vitamins or minerals
Liver involvement
Unintentional weight loss
CVID enteropathy can resemble coeliac disease under the microscope, but it may not respond to a gluten-free diet in the same way. This is one reason why persistent symptoms should be investigated rather than assumed to be ordinary irritable bowel syndrome or food intolerance.
Appropriate investigation may involve stool tests, blood tests, nutritional assessment, endoscopy and biopsy. Routine endoscopy is not necessary for every person with CVID, but it may be recommended when diarrhoea, anaemia, abdominal pain or weight loss persists.
Can CVID affect the liver?
Yes. Liver abnormalities are increasingly recognised in CVID.
Some people develop abnormal liver blood tests without obvious symptoms. Others may develop nodular regenerative hyperplasia, fibrosis, portal hypertension or enlargement of the liver and spleen.
Portal hypertension means increased pressure in the vein carrying blood through the liver. It can lead to an enlarged spleen, low platelet count, fluid accumulation or enlarged veins in the oesophagus.
A UK multicentre study and other recent research have emphasised that inflammatory lung disease, liver disease and other non-infectious complications deserve active surveillance rather than assuming that immunoglobulin replacement alone addresses every aspect of CVID.
Is there an increased cancer risk with CVID?
People with CVID have an increased risk of certain cancers, particularly cancers of the lymphatic system. Some studies have also found an increased risk of gastric or other gastrointestinal cancers.
This does not mean that most people with CVID will develop cancer.
Persistent lymph-node enlargement is common and is often reactive rather than malignant. Nevertheless, clinicians may investigate lymph nodes that are new, growing, unusually firm or associated with symptoms such as unexplained weight loss, drenching night sweats or persistent fever.
The overall cancer pattern is more complicated than saying that every common cancer is increased. Patient-registry data have not shown a significant increase in all major cancers, while lymphoma and selected gastrointestinal malignancies remain of particular concern.
How is CVID diagnosed?
CVID is a diagnosis made from several pieces of evidence rather than one positive test.
The assessment is normally led by a clinical immunologist and may include the following.
Medical and infection history
The clinician will ask about:
The number and type of infections
Whether antibiotics were required
How quickly infections returned
Hospital admissions
Previous pneumonias
Chronic cough or sputum
Digestive symptoms
Autoimmune disease
Unexplained low blood-cell counts
Enlarged lymph nodes or spleen
Family history
Current and previous medicines
Old medical records can be valuable because they may reveal a pattern that was not obvious when each infection occurred separately.
Immunoglobulin blood tests
Blood tests measure IgG, IgA and IgM.
In CVID, IgG is substantially reduced, with a reduction in IgA, IgM or both. Abnormal results are usually confirmed on more than one occasion rather than relying on a single measurement taken during an acute illness.
A mildly low immunoglobulin result does not automatically mean CVID. Results must be compared with age-adjusted laboratory ranges and interpreted alongside the clinical picture.
Vaccine-response testing
Doctors may assess whether the immune system can produce antibodies after vaccination.
Blood is taken before and after selected non-live vaccines to measure the antibody response. A poor response supports the presence of a functional antibody deficiency.
This testing is ideally completed before immunoglobulin replacement begins because donor antibodies within the treatment can make later results difficult to interpret. Functional antibody testing is considered an important part of evaluating suspected CVID.
Lymphocyte testing
Flow cytometry can measure different types of B cells and T cells.
Some people with CVID have low numbers of switched memory B cells, the cells that normally retain information about previous infections and produce specialised antibodies when needed. These results can help classify the immune abnormality and identify patients who may need evaluation for a combined or genetically defined immune deficiency.
Tests for complications
Depending on the symptoms, additional investigations may include:
Full blood count
Liver and kidney blood tests
Inflammatory markers
Lung-function testing
Chest X-ray
High-resolution chest CT
Stool tests
Nutritional blood tests
Abdominal ultrasound
Endoscopy
Lymph-node biopsy
Bone-marrow examination
Genetic testing
Regular lung assessment is particularly important when there is chronic cough, breathlessness, repeated pneumonia or known bronchiectasis.
Why is CVID a diagnosis of exclusion?
Several conditions can cause low immunoglobulin levels without being CVID.
Doctors must consider secondary causes such as:
Medicines that suppress immune function
Rituximab and other B-cell-depleting treatments
Certain anticonvulsants
Blood cancers
Lymphoma or chronic lymphocytic leukaemia
Nephrotic syndrome
Protein-losing bowel disease
HIV
Severe malnutrition
Previous chemotherapy
Bone-marrow disorders
Other defined primary immunodeficiencies
This distinction matters because treatment and prognosis may be different.
A person with low IgG caused by medication or protein loss should not automatically be given a permanent CVID diagnosis. Recognised diagnostic frameworks require other causes of hypogammaglobulinaemia to be excluded.
Can you have CVID without frequent infections?
Yes.
Some patients first present with autoimmunity, enlarged lymph nodes, splenomegaly, inflammatory lung disease, liver disease or gastrointestinal inflammation.
Others may previously have received frequent antibiotics that masked the extent of the infection problem. A person may also change their activities to avoid exposure without realising how much their health has shaped daily life.
Modern descriptions increasingly separate infection-only CVID from complicated CVID, in which immune-mediated and inflammatory problems occur alongside or independently of infections.
Is CVID the same as an autoimmune disease?
Not exactly.
CVID is primarily classified as an inborn error of immunity or primary immunodeficiency. However, immune dysregulation is a major part of the condition, and autoimmune disease is common.
It is therefore possible for someone with CVID to be both immunodeficient and autoimmune. The immune system may fail to produce effective protective antibodies while simultaneously attacking platelets, red blood cells or other tissues.
Is CVID the same as AIDS?
No.
AIDS is an acquired immune deficiency caused by untreated infection with the human immunodeficiency virus, or HIV.
CVID is not caused by HIV. It is usually considered a primary or inborn immune disorder, even when it does not become apparent until adulthood.
Both conditions can make infections more likely, but they affect the immune system differently, require different tests and are treated differently.
Is CVID the same as selective IgA deficiency?
No, although the two conditions can be related.
In selective IgA deficiency, IgA is low or absent while IgG and IgM are generally within their expected ranges. Many people with selective IgA deficiency have few or no symptoms.
CVID involves a significant reduction in IgG as well as reduced IgA, IgM or both, together with impaired antibody function.
Some people initially diagnosed with selective IgA deficiency later develop a broader antibody deficiency resembling CVID. This does not happen to everyone.
Is CVID contagious?
No. CVID cannot be passed from person to person through coughing, physical contact, food, blood or sexual activity.
A person with CVID may acquire a contagious infection, such as influenza, in the same way as anyone else. The difference is that the infection may be harder for their immune system to control.
How is CVID treated?
There is currently no single treatment that corrects every immune abnormality associated with CVID.
Management usually includes:
Replacing missing antibodies
Treating and preventing infections
Monitoring the lungs and other organs
Treating autoimmune and inflammatory complications
Supporting quality of life
Immunoglobulin replacement therapy
Immunoglobulin replacement is the main treatment for most people with confirmed CVID.
The product is made from plasma donated by many screened healthy donors. It contains a broad mixture of IgG antibodies against infections commonly encountered in the population.
Replacement treatment does not stimulate the patient’s immune system to make its own antibodies. It supplies ready-made antibodies that remain in the circulation for a limited time. Treatment therefore needs to be repeated regularly.
Immunoglobulin replacement can be given by two main routes.
Intravenous immunoglobulin
Intravenous immunoglobulin, or IVIG, is infused into a vein.
Treatment may be given in hospital, an infusion centre or at home, depending on local services and the patient’s circumstances. It is often administered every three or four weeks, although schedules vary.
Possible effects during or after an infusion include:
Headache
Tiredness
Chills
Muscle aches
Nausea
Fever
Changes in blood pressure
Slowing the infusion, adjusting the product, ensuring appropriate hydration or using premedication may help selected patients. Serious reactions are uncommon but require medical attention.
Subcutaneous immunoglobulin
Subcutaneous immunoglobulin, or SCIG, is infused into the fatty tissue under the skin.
Smaller amounts are generally given more frequently, often once or several times a week. Many people learn to administer treatment at home.
Local swelling, redness or itching can occur around the infusion site, particularly when treatment is first started.
Neither IVIG nor SCIG is inherently best for every person. Treatment should be tailored according to infection control, side effects, venous access, lifestyle, patient preference and the ability to manage home therapy.
How is the immunoglobulin dose decided?
The dose is individualised.
Specialists consider:
Body weight
Frequency of infections
Existing bronchiectasis or lung disease
IgG levels between infusions
Side effects
Protein loss through the bowel or kidneys
The route and frequency of treatment
The aim is not merely to reach a particular laboratory number. The more important goal is to reduce serious and recurrent infections while avoiding unacceptable treatment effects.
Some patients need a higher dose to remain well, especially when they already have bronchiectasis or continue to experience infections.
Does immunoglobulin cure CVID?
No. Immunoglobulin replacement does not cure the underlying immune disorder.
It can substantially reduce bacterial infections and help prevent further infection-related lung damage. It has greatly improved the outlook for people with CVID.
However, replacement Ig does not reliably control every complication. Autoimmunity, GLILD, liver disease, enteropathy, lymphoproliferation and malignancy may require separate investigation and treatment.
Are antibiotics still needed?
Yes, when a bacterial infection develops.
Some people also receive preventive antibiotics if infections continue despite adequate immunoglobulin replacement or if significant bronchiectasis is present.
Whenever possible, sputum, urine or other relevant samples may be collected so that treatment can be directed towards the organism involved.
People with CVID should follow the antibiotic plan provided by their clinical team. Using leftover antibiotics, shortening a prescribed course or repeatedly self-treating symptoms can delay identification of resistant or non-bacterial infections.
How are autoimmune and inflammatory complications treated?
Treatment depends on the organ involved and the severity of the problem.
Options may include:
Corticosteroids
Rituximab
Other immune-modifying medicines
Treatment for inflammatory bowel disease
Therapy for autoimmune cytopenias
Respiratory treatment for GLILD
Management of portal hypertension
Cancer-specific treatment
This creates a clinical balancing act. Suppressing harmful inflammation may be necessary, but excessive immunosuppression can further increase infection risk.
For this reason, complicated CVID is often managed by several specialties working together.
Is a bone-marrow transplant used for CVID?
Haematopoietic stem-cell transplantation is not standard treatment for typical CVID.
It carries substantial risks and is generally reserved for exceptional patients with severe, life-threatening immune dysregulation or a defined genetic immune disorder for which transplantation offers a realistic chance of benefit.
Most patients are treated with immunoglobulin replacement and targeted management of their individual complications.
Can people with CVID have vaccines?
Vaccination requires individual advice from the patient’s immunology team.
People with significant antibody deficiencies may respond poorly to vaccines. Immunoglobulin products also contain donor antibodies against many infections, which can interfere with the interpretation or effectiveness of certain vaccinations.
Live vaccines can create a risk in some immunodeficient patients and may need to be avoided. However, the degree of immune impairment varies, and advice is not identical for every person.
Inactivated vaccines cannot cause the infection they are designed to prevent, but their effectiveness may be reduced. Certain non-live vaccines may still be recommended, including vaccines intended to provide additional protection against seasonal or emerging infections.
Patients should not assume that every vaccine is unsafe or that every vaccine will work normally. They should obtain specific advice before receiving a live vaccine or travelling to a country requiring additional immunisations.
Can a person with CVID travel?
Many people with well-managed CVID travel successfully.
Planning may involve:
Discussing the destination with the immunology team
Reviewing vaccine requirements
Checking whether a required live vaccine is appropriate
Carrying enough regular medication
Transporting immunoglobulin safely
Taking a clinician’s letter for medication and equipment
Arranging travel insurance that covers the condition
Identifying suitable medical services at the destination
Taking prescribed standby antibiotics where recommended
Using food and water precautions in higher-risk areas
Donor immunoglobulin contains antibodies against infections circulating commonly within the donor population, but it does not provide complete protection against every disease encountered abroad.
Can someone with CVID work?
Many people with CVID continue to work, study, raise families and lead active lives.
The degree of difficulty depends on infection frequency, fatigue, organ complications and the practical demands of regular treatment. Flexible working, home infusions or adjustments during periods of illness may help.
Immunodeficiency UK notes that effective immunoglobulin treatment and antibiotics allow many people with CVID to live relatively normal lives without general restrictions on employment.
People working in healthcare, education, farming or other high-exposure environments should discuss their individual risks rather than assuming they must leave their occupation.
Can people with CVID exercise?
Exercise is usually beneficial when adapted to the person’s health and medical advice.
Someone without significant organ damage may be able to exercise normally. A person with bronchiectasis, GLILD, anaemia or active infection may need a graded programme and assessment by respiratory medicine or physiotherapy.
Airway-clearance exercises can be particularly important for people with bronchiectasis. Sudden breathlessness, chest pain, fainting or coughing up blood requires medical assessment rather than simply reducing exercise intensity.
Is there a special CVID diet?
There is no single diet that treats CVID.
A balanced diet supports general health but cannot replace missing antibodies. Dietary changes should be based on specific problems such as:
Coeliac disease
Lactose intolerance
Malabsorption
CVID enteropathy
Vitamin deficiencies
Liver disease
Unintentional weight loss
Unsupervised exclusion diets may worsen nutritional deficiencies, especially in someone who already has malabsorption or chronic diarrhoea.
Persistent digestive symptoms warrant proper investigation rather than repeatedly removing foods without a diagnosis.
What is it like living with CVID?
The burden of CVID is not always visible.
A person may look well between infections while managing:
Regular infusions
Repeated antibiotics
Fatigue
Unpredictable illness
Medical appointments
Anxiety about infection exposure
Treatment side effects
Chronic cough or bowel symptoms
Difficulty explaining the condition to employers
Concern about long-term complications
Some patients describe feeling as though they must constantly judge whether a sore throat or cough can be watched at home or needs urgent treatment.
Psychological support can be useful, particularly after years of unexplained illness or diagnostic delay. This does not imply that the symptoms are psychological. Chronic disease naturally affects confidence, relationships, work and emotional wellbeing.
Does CVID get worse with age?
CVID does not follow one predictable course.
Some people remain stable for many years once immunoglobulin treatment is established. Others develop bronchiectasis, autoimmunity, bowel inflammation, liver disease or GLILD.
Progression is influenced by:
How long the condition went undiagnosed
Lung or organ damage already present
Effectiveness of infection prevention
The presence of immune dysregulation
Individual genetic and biological factors
Access to appropriate monitoring and treatment
The condition does not necessarily deteriorate continuously. A person may have long stable periods, intermittent complications or substantial improvement after effective treatment.
What is the life expectancy with CVID?
There is no single, dependable life-expectancy figure that applies to every person with CVID.
Immunoglobulin replacement and improved infection treatment have transformed prognosis. Fatal bacterial infections have become less common, and many people now live for decades following diagnosis.
Older survival figures found online should be treated cautiously. They may include patients diagnosed before modern immunoglobulin treatment became widely available, and they often combine people with uncomplicated infection-only CVID with those who have serious inflammatory disease or cancer.
For many patients whose main problem is recurrent infection, effective immunoglobulin replacement can provide a favourable outlook. Prognosis is more guarded when CVID is accompanied by:
Interstitial lung disease or GLILD
Significant bronchiectasis
Liver disease or portal hypertension
Severe enteropathy
Lymphoma or another malignancy
Recurrent autoimmune cytopenias
Persistent lymphoproliferation
Severe or difficult-to-control infections
Recent research continues to show a clear difference between infection-only CVID and complicated CVID. Immunoglobulin treatment is highly effective at reducing many infections, but it does not remove the risks created by inflammatory organ disease, immune dysregulation or malignancy.
The most accurate answer to “How long can someone live with CVID?” is therefore that many people can have a near-normal or long lifespan, but individual prognosis depends heavily on complications, organ damage and treatment response.
What improves the outlook?
Important factors include:
Early recognition
Starting appropriate immunoglobulin replacement
Prompt treatment of bacterial infections
Monitoring lung function
Investigating chronic cough and breathlessness
Preventing further bronchiectasis
Recognising autoimmune blood disorders
Investigating persistent diarrhoea and weight loss
Monitoring liver and spleen abnormalities
Assessing persistent lymph-node enlargement
Coordinated specialist follow-up
The outlook depends partly on how much lung or organ damage developed before diagnosis and how successfully future infections and inflammatory complications can be controlled.
When should someone seek urgent medical help?
A person with CVID should seek urgent assessment for symptoms such as:
Severe difficulty breathing
Blue or grey lips
Chest pain
Confusion or loss of consciousness
Coughing up more than a small streak of blood
A rapidly spreading infection
Signs of sepsis
Inability to keep fluids down
Severe dehydration
New unexplained bleeding
A high fever with marked deterioration
Severe abdominal pain
Sudden weakness or neurological symptoms
The patient’s own clinical team may provide a lower threshold for assessment because serious infection can progress without producing the usual immune response.
Questions to ask an immunologist
Useful questions include:
Which immunoglobulins are low?
Were the results confirmed on more than one test?
How well did I respond to vaccines?
Have secondary causes been excluded?
Do I need B-cell and T-cell testing?
Would genetic testing be useful?
Do I have bronchiectasis or inflammatory lung disease?
Should I have regular lung-function tests?
Which infections should be treated urgently?
Would IVIG or SCIG suit me better?
What is my plan for breakthrough infections?
Are there any vaccines I should avoid?
Which symptoms could indicate an autoimmune complication?
How will my liver, bowel and lymph nodes be monitored?
What should I do before travelling?
Frequently asked questions
Can CVID be mild?
Yes. Some people mainly experience recurrent sinus infections and remain otherwise well. Others develop serious immune dysregulation or organ complications.
The diagnosis should still be taken seriously because repeated infections can cause permanent damage even when each individual illness seems manageable.
Can CVID be cured?
There is currently no routine cure for typical CVID. Immunoglobulin replacement and other treatments can control infections and complications but do not permanently restore normal antibody production.
Is CVID fatal?
CVID is not inevitably fatal. Many people live for decades with appropriate treatment.
Severe infections, lung disease, liver disease, autoimmune complications and certain cancers can nevertheless be life-threatening.
Does CVID cause fatigue?
Fatigue is frequently reported. It may relate to infection, inflammation, sleep disturbance, anaemia, treatment effects or chronic organ disease.
New or worsening fatigue should not automatically be attributed to CVID because thyroid disease, iron deficiency, medication effects and many other treatable conditions are also possible.
Does CVID cause weight loss?
It can, particularly when chronic infection, enteropathy or malabsorption affects the digestive system.
Unintentional weight loss requires medical assessment and should not be assumed to be an expected part of CVID.
Can CVID appear suddenly?
Symptoms may seem to appear suddenly, especially after a severe infection, but the underlying immune problem may have been developing or going unrecognised for some time.
Can CVID go into remission?
Symptoms can improve substantially with treatment, and a person may remain stable for long periods. However, established CVID is generally considered a lifelong diagnosis.
Can CVID cause swollen lymph nodes?
Yes. Benign lymph-node enlargement is relatively common, but persistent or changing nodes may need investigation to exclude infection, inflammatory disease or lymphoma.
Does CVID affect fertility or pregnancy?
Many people with CVID can have successful pregnancies. Pre-conception planning and communication between immunology and maternity teams are important.
Immunoglobulin replacement is generally continued during pregnancy and may require monitoring or dose adjustment as the pregnancy progresses. It also helps provide protective maternal antibodies to the baby.
Can children inherit CVID from a parent?
Most cases do not follow a straightforward inheritance pattern. The risk depends on whether a specific genetic cause has been found and on the family history.
A clinical geneticist or genetic counsellor can provide individual advice.
A realistic outlook
CVID is much more than a tendency to catch infections.
For some people, antibody replacement brings a dramatic reduction in illness and allows normal work, travel and family life. For others, the greatest difficulties come from inflammatory disease, lung damage, bowel problems, autoimmunity or fatigue rather than infection alone.
The condition is also easy to miss. A sinus infection is common. Diarrhoea is common. Fatigue is common. Even pneumonia can occur in someone with an otherwise healthy immune system. CVID becomes more likely when these events form a persistent pattern and are accompanied by low immunoglobulins and poor antibody function.
The diagnosis should not be made from symptoms alone, and it should not be based on one borderline blood result. A careful assessment must confirm the immune abnormality and exclude medicines, protein loss, cancer and other immune disorders that can produce similar findings.
Once diagnosed, treatment should be broader than simply checking an IgG level. Preventing infection is essential, but so is protecting the lungs, investigating persistent digestive symptoms, monitoring blood counts and recognising immune-mediated complications early.
With appropriate immunoglobulin replacement and specialist follow-up, many people with CVID can lead active and fulfilling lives.
Medical disclaimer
This article is provided for general education and does not diagnose common variable immunodeficiency or replace individual medical advice.
Recurrent infections, fatigue, diarrhoea and low immunoglobulin levels can have many causes. Anyone concerned about persistent or unusually severe infections should speak to a qualified healthcare professional. People already diagnosed with CVID should follow the treatment, vaccination and emergency advice provided by their own immunology team.
Do not start or stop antibiotics, immunoglobulin treatment or immune-suppressing medication without medical guidance.
References and further reading
Immunodeficiency UK. Common variable immune deficiency disorders.
Immune Deficiency Foundation. Common variable immune deficiency.
American Academy of Allergy, Asthma and Immunology. Common Variable Immunodeficiency.
European Society for Immunodeficiencies. Diagnosis Criteria.
Bintalib HM and colleagues. Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study. Frontiers in Immunology, 2024.
Remiker A and Cunningham-Rundles C. Common Variable Immunodeficiency. 2024.
Cunningham-Rundles C. Current concepts: Common variable immunodeficiency. 2025.
Immune Deficiency Foundation. Immunoglobulin replacement therapy.
Immunodeficiency UK. Immunisation in immunodeficiency.
American Academy of Allergy, Asthma and Immunology. Which are the patients with CVID who die too early? 2025.